The ApoB/ApoA1 ratio compares apolipoprotein B — the protein found on every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)) — with apolipoprotein A1, the main structural protein of protective HDL particles. It captures both the atherogenic burden and the protective capacity in a single ratio.

Research has shown the ApoB/ApoA1 ratio is one of the strongest predictors of cardiovascular risk available — superior to total cholesterol, LDL alone, or the standard cholesterol ratio in multiple large studies. A higher ratio means more atherogenic particles relative to protective ones. It is particularly useful in people with metabolic syndrome where standard lipid panels may appear deceptively normal.